Provoked vestibulodynia

Women's Health

Volumn 3, Issue 5, 2007, Pages 583-592

  Pukall, Caroline F ^a   Smith, Kelly B ^a   Chamberlain, Susan M ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Antidepressant medication; Botox; Dyspareunia; Lidocaine; Pelvic floor physical therapy biofeedback; Psychological treatments; Vestibulectomy; Vestibulitis; Vestibulodynia; Vulvodynia

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BOTULINUM TOXIN A; CITRATE CALCIUM; CROMOGLYCATE DISODIUM; ESTROGEN; GLYCERYL TRINITRATE; LIDOCAINE; OXALIC ACID; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; DIET THERAPY; DYSPAREUNIA; EVENING DOSAGE; FEEDBACK SYSTEM; HEALTH CARE QUALITY; HUMAN; HUMAN RELATION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PROVOKED VESTIBULODYNIA; PSYCHOLOGICAL WELL BEING; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX THERAPY; SEXUAL FUNCTION; SURGICAL RISK; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; VULVODYNIA;

EID: 35848937178     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.3.5.583     Document Type: Review

References (71)

1. Harlow BL, Wise LA, Stewart, EG: Prevalence and predictors of chronic lower genital tract discomfort. Am. J. Obstet. Gynecol. 185, 545-550 (2001).
2. Haefner HK: Report of the International Society for the Study of Vulvovaginal Disease Terminology and Classification of Vulvodynia. J. Low. Genit. Tact Dis. 11, 48-49 (2007).
3. Bergeron S, Binik YM, Khalifé S, Pagidas K, Glazer HI: Vulvar vestibulitis syndrome: Reliability and evaluation of current diagnostic criteria. Obstet. Gynecol. 98, 45-51 (2001).
4. Harlow BL, Stewart EG: A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J. Am. Med. Womens Assoc. 58, 82-88 (2003).
5. Pukall CF, Payne KA, Kao A, Khalifé S, Binik YM: Dyspareunia. In: Handbook of Sexual Dysfunction. Balon R, Segraves RT (Eds.). Taylor & Francis, NY, USA, 249-272 (2005).
6. Payne KA, Bergeron S, Khalifé S, Binik YM: Assessment, treatment strategies and outcome results: Perspective of pain specialists. In: Women's Sexual Function and Dysfunction: Study, Diagnosis, and Treatment. Goldstein I, Meston CM, Davis SR, Traish AM (Eds.). Taylor & Francis, NY, USA, 471-479 (2006).
7. Farage MA, Galask RP: Vulvar vestibulitis syndrome. In: The Vulva: Anatomy, Physiology, and Pathology. Farage MA, Maibach HI (Eds.). Informa Healthcare, NY, USA, 101-114 (2006).
8. Bornstein J, Goldik Z, Stolar Z, Zarfati D, Abramovicl H: Predicting the outcome of surgical treatment of vulvar vestibulltis. Obstet. Gynecol. Surv. 52, 618-619 (1997).
9. Pukall CF, Bergeron S, Goldfinger C: Vulvodynia: A review of pathophysiological factors and treatment options. Basic. Clin. Med. (2007) (In Press).
10. Buchan A, Munday P, Ravenhill G, Wiggs A, Brooks F: A qualitative study of women with vulvodynia: I. The journey into treatment. J. Reprod. Med. 52, 15-18 (2007).
11. Friedrich EG Jr: Vulvar vestibulitis syndrome. J. Reprod. Med. 32, 110-114 (1987).
12. Pukall CF, Payne KA, Binik YM, Khalifé S: Pain measurement in vulvodynia. J. Sex. Marital. Ther. 29(Suppl.), 111-120 (2003).
13. Pukall CF, Binik YM, Khalifé S: A new instrument for pain assessment in vulvar vestibulitis syndrome. J. Sex. Marital. Ther. 30, 69-78 (2004).
14. Pukall CF, Lahaie MA, Binik YM: Sexual pain disorders: Pathophysiological factors. In: Women's Sexual Function and Dysfunction: Study, Diagnosis, and Treatment. Goldstein I, Meston CM, Davis SR, Traish AM (Eds.). Taylor & Francis, NY, USA, 236-242 (2006).
15. Bornstein J, Goldschmid N, Sabo E: Hyperinnervation and mast cell activation may be used as histopathological diagnostic criteria for vulvar vestibulitis. Gynecol. Obstet. Invest. 58, 171-178 (2004).
16. Bohm-Starke N, Falconer C, Rylander E, Hilliges M: The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis. Acta. Obstet. Gynecol. Scand. 80, 638-644 (2001).
17. Tympanidis P, Terenghi G, Dowd P: Increased innervation of the vulval vestibule in patients with vulvoclynia. Br. J. Dermatol. 148, 1021-1027 (2003).
18. Tympanidis F, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P: Increased vanilloid receptor VR1 innervation in vulvodynia. Eur. J. Pain. 8, 129-133 (2004).
19. Bohm, Starke N, Hilliges M, Blomgren BO, Falconer C, Rylander E: Increased blood flow and erythema in the posterior vestibular mucosa in vulvar vestibulitis. Obstet. Gynecol. 98, 1067-1074 (2001).
20. Pukall CF, Binik YM, Khalifé S, Amsel R, Abbott FV: Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 96, 163-175 (2002).
21. Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjork E: Psychophysical evidence of nociceptor sensitisation in vulvar vestibulitis syndrome. Pain 94, 177-183 (2001).
22. de Lima J, Alvares D, Hatch DJ, Fitzgerald M: Sensory hyperinnervation after neonatal skin wounding: Effect of bupivocaine sciatic nerve block. Br. J. Anaesth. 83, 662-664 (1999).
23. Reissing ED, Brown C, Lord MJ, Binik YM, Khalifé S: Pelvic floor muscle function in women with vulvar vestibulitis syndrome. J. Psychosom. Obstet. Gynecol. 26, 107-113 (2005).
24. Bazin S, Bouchard C, Brisson J, Morin C, Meisels A, Fortier M: Vulvar vestibulitis syndrome: An exploratory case-control study. Obstet. Gynecol. 83, 47-50 (1994).
25. Bouchard C, Brisson J. Fortier M, Morin C, Blanchette C: Use of oral contraceptives and vulvar vestibulitis: A case-control study. Am. J. Epidemiol. 156, 254-261 (2002).
26. Bohm-Starke N, Johannesson U, Hilliges M, Rylander E, Torebjork E: Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives. J. Reprod. Med. 49, 283-290 (2004).
27. Drexler B, Landthaler M, Hohenleutner S: The menstrual cycle and the skin. In: The Vulva: Anatomy, Physiology and Pathology. Farage MA, Maibach HI (Eds.). Informa Healthcare, NY, USA, 167-181 (i006).
28. Goldstein I, Alexander JL: Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J. Sex. Med. 2(Suppl. 3), 154-165 (2005).
29. Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS: Interleukin-1B-gene polymorphism in women with vulvar vestibulitis syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 107, 74-77 (2003).
30. Pukall CF, Baron M, Amsei R, Khalifé S, Binik YM: Tender point examination in women with vulvar vestibulitis syndrome. Clin. J. Pain 22, 601-109 (2006).
31. Danielsson I, Eisemann M, Sjöberg I, Wikman M: Vulvar vestibulitis: a multi-factorial condition. Br. J. Obstet. Gynaecol. 108, 456-461 (2001).
32. Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely, RH: Quantitative sensory testing in vulvodynia patients and increased peripheral pressure sensitivity. Obstet. Gynecol. 104, 126-133 (2004).
33. Granot M, Friedman M, Yarnitsky D, Zimmer EZ: Enhancement of the perception of systemic pain in women with vulvar vestibulitis. Br. J. Obstet. Gynaecol. 109, 863-866 (2002).
34. Johannesson U, Nygren de Boussard C, Brodda Jansen C, Bohm-Starke N: Evidence of diffuse noxious inhibitory control (DNIC) elicited by cold noxious stimulation in patients with provoked vestibulodynia. Pain doi:10.1016/j.pain.2006.10.022. (2007) (Epub ahead of print).
35. Pukall CF, Strigo IA: Binik YM, Amsel R, Khalifé S, Bushnell MC: Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome. Pain 115, 118-127 (2005).
36. Kuchinad A, Pukall CF, Bushnell MC: Changes in grey matter density associated with vulvar vestibulitis syndrome. Program No. 445.24. 2006 Neuroscience Meeting Planner, Atlanta, GA: Society for Neuroscience. Online (2006).
37. Weijmar-Schultz W, Basson R, Binik Y, Eschenbach D, Wesselmann U, van Lankveld J: Women's sexual pain and its management. J. Sex. Med. 2, 301-316 (2005).
38. Arnold LD, Bachmann GA, Rosen RA, Kelly S, Rhoads GG: Vulvodynia: Characteristics and associations with comorbidities and quality of life. Obstet. Gynecol. 107, 617-624 (2006).
39. Gates EA, Galask RP: Psychological and sexual functioning in women with vulvar vestibulitis. J. Psychom. Obstet, Gyn. 22, 221-228 (2001).
40. Masheb RM, Brondolo E, Kerns RD: A multidimensional, case-control study of women with self-identified chronic vulvar pain, Pain Med. 3, 253-259 (2002).
41. Reed BD, Advincula AP, Fonde KR, Gorenflo DW, Haefner HK: Sexual activities and attitudes of women with vulvar dysesthesia. Obstet. Gynecol. 102, 325-331 (2003).
42. Gordon A, Panahian Jand M, McComb F, Melegari C, Sharpe S: Characteristics of women with vulvar pain disorders: Responses to a web-based survey. J. Sex. Marital Ther. 29, 45-58 (2003).
43. Meana M, Binik YM, Khalifé S, Cohen D: Psychosocial correlates of pain attributes in women with dyspareunia. Psychosomatics 40, 497-502 (1999).
44. Binik I, Bergeron S: Chronic vulvar pain and sexual functioning. NVA News Spring, 5-7(2001).
45. Meana M, Binik YM, Khalifé S, Cohen D: Biopsychosocial profile of women with dyspareunia. Obstet. Gynecol. 90, 583-589 (1997).
46. Arnold LD, Bachmann GA, Rosen R, Rhoads GG: Assessment of vulvodynia symptoms in a sample of US women: a prevalence study with a nested case control study. Am. J. Obstet. Gynecol. 196(2), 128.el-128e.6 (2007).
47. Bornstein J, Zarfati D, Goldik Z, Abramovici H: Vulvar vestibulitis: Physical or psychosexual problem? Obstet. Gynecol. 93, 876-880 (1999).
48. van Lankveld, JJDM, Weijenborg PTM, Ter Kuile MM: Psychologic profiles of and sexual function in women with vulvar vestibulitis and their partners. Obstet. Gynecol. 88, 65-70 (1996).
49. Zolnoun DA, Hartmann KE, Steege JF: Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet. Gynecol. 102, 84-87 (2003).
50. Nyierjesy, P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP: Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: Results of a placebo controlled study. Sex. Transm. Infect. 77, 53-57 (2001).
51. Haefner HK, Collins ME, Davis, GD et al.: The vulvodynia guideline. J. Low. Genit. Tract Dis. 9, 40-51 (2005).
52. Reed BD, Caron AM, Gorenflo DW, Haefner HK: Treatment of vulvodynia with tricyclic antidepressants: Efficacy and associated factors. J. Low. Genit. Tract Dis. 10, 245-251 (2006).
53. Lavy Y, Lev-Sagie A, Hamani Y, Zacut D, Ben-Chetrit A: Modified vulvar vestibulectomy: Simple and effective surgery for the treatment of vulvar vestibulitis. Eur. J. Obstet. Gynecol. Reprod. Biol. 120, 91-95 (2005).
54. Reed BD: Vulvodynia: diagnosis and management. Am. Fam. Physician 73, 1231-1238 (2006).
55. Goldstein AT, Klingman D, Christopher K, Johnson C, Marinoff SC: Surgical treatment of vulvar vestibulitis syndrome: outcome assessment derived from a postoperative questionnaire. J. Sex. Med. 3, 923-931 (2006).
56. Bergeron S, Binik YM, Khalifé S, Pagidas K: Vulvar vestibulitis syndrome: a critical review. Clin. J. Pain. 13, 27-42 (1997).
57. Bergeron S, Binik YM, Khalifé S et al.: A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 91, 297-306 (2001).
58. Bergeron S, Binik YM, Khalifé S: In favor of an integrated pain-relief treatment approach for vulvar vestibulitis syndrome. J. Psychosom. Obstet. Gynaecol. 23, 7-9 (2002).
59. Goldstein A: Surgery for vulvar vestibulitis syndrome. J. Sex. Med. 3, 559-562 (2006).
60. Bergeron S, Lord MJ: The integration of pelvi-perineal re-education and cognitive-behavioral therapy in the multidisciplinary treatment of the sexual pain disorders. Sex. Relat. Ther. 18, 135-141 (2003).
61. Weijmar Schultz WC, Gianotten WL, van der Meijden WI et al.: Behavioral approach with or without surgical intervention to the vulvar vestibulitis syndrome: a prospective randomized and non-randomized study. J. Psychosom. Obstet. Gynaecol. 17, 143-148 (1996).
62. Pukali CF, Kandyba K, Amsel R, Khalifé S, Bink YM: Effectiveness of hypnosis for the treatment of vulvar vestibulitis syndrome: a preliminary investigation. J. Sex. Med. 4, 417-425 (2007).
63. Powell J. Wojnarowska F: Acupuncture for vulvodynia. J. R. Soc. Med. 92, 579-581 (1999).
64. Reissing ED, Binik YM, Khalifé S, Cohen D, Amsel R: Vaginal spasm, pain and behavior: An empirical Investigation of the diagnosis of vaginisnius. Arch. Sex. Behav. 33, 5-17 (2004).
65. Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW: The treatment of vulvar vestibulitis syndrome by electromyographic biofeedback of pelvic-floor musculature. J. Reprod. Mad. 40, 283-290 (1995).
66. McKay E, Kaufman RH, Doctor U, Berkova Z, Glazer HI, Redko V: Treating vulvar vestibutitis with electromyographic biofeedback of pelvic-floor musculature. J. Reprod. Med. 46, 337-342 (2001).
67. Danielsson I, Torstensson T, Brodda-Jansen G, Bohm-Starke N: EMG biofeedback versus topical lidocaine gel: a randomized study for treatment of women with vulvar vestibulitis. Acta. Obstet. Gynecol. Scand. 85, 1360-1367 (4006).
68. Hartmann D, Strauhal MJ, Nelson CA: Treatment of women in the United States with localized, provoked vulvodynia: practice survey of women's health physical therapists. J. Reprod. Med. 52, 48-52 (2007).
69. Bergeron S, Brown C, Lord MJ, Oala M, Binik YM, Khalifé S: Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J. Sex. Marital. Ther. 28, 183-192 (2002).
70. Updike GM, Wiesenfeld HC: Insight into the treatment of vulvar pain: a survey of clinicians. Am. J. Obstet. Gynecol. 193, 1404-1409 (2005).
71. Yoon H, Chung WS, Shim BS: Botulinum toxin A for the management of vulvodynia. Int. J. Impot. Res. 19, 84-87 (2006).